Mostrar el registro sencillo del ítem

dc.rights.licenseopenen_US
hal.structure.identifierImmunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept]
dc.contributor.authorMIGAYRON, Laure
dc.contributor.authorBORDES, Sylvie
dc.contributor.authorCLOSS, Brigitte
hal.structure.identifierImmunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept]
dc.contributor.authorSENESCHAL, Julien
hal.structure.identifierImmunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept]
dc.contributor.authorBONIFACE, Katia
IDREF: 10566913X
dc.date.accessioned2025-01-15T13:38:07Z
dc.date.available2025-01-15T13:38:07Z
dc.date.issued2024-05
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/204294
dc.description.abstractEnChronic inflammatory skin diseases are multifactorial diseases that combine genetic predisposition, environmental triggers, and metabolic disturbances associated with abnormal immune responses. From an immunological perspective, the better understanding of their physiopathology has demonstrated a large complex network of immune cell subsets and related cytokines that interact with both epidermal and dermal cells. For example, in type-1-associated diseases such as alopecia areata, vitiligo, and localized scleroderma, recent evidence suggests the presence of a type-2 inflammation that is well known in atopic dermatitis. Whether this type-2 immune response has a protective or detrimental impact on the development and chronicity of these diseases remains to be fully elucidated, highlighting the need to better understand its involvement for the management of patients. This mini-review explores recent insights regarding the potential role of type-2-related immunity in alopecia areata, vitiligo, and localized scleroderma.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subject.enType-1 immunity
dc.subject.enType-2 immunity
dc.subject.enAtopic dermatitis
dc.subject.enLocalized scleroderma
dc.subject.enAlopecia areata
dc.subject.enVitiligo
dc.title.enType-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
dc.typeArticle de revueen_US
dc.identifier.doi10.3389/fimmu.2024.1405215en_US
dc.subject.halSciences du Vivant [q-bio]/Immunologieen_US
bordeaux.journalFrontiers in immunologyen_US
bordeaux.volume15en_US
bordeaux.hal.laboratoriesImmunoConcEpT - UMR 5164en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionCNRSen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-04888607
hal.version1
hal.date.transferred2025-01-15T13:38:11Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
dc.rights.ccCC BYen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Frontiers%20in%20immunology&rft.date=2024-05&rft.volume=15&rft.au=MIGAYRON,%20Laure&BORDES,%20Sylvie&CLOSS,%20Brigitte&SENESCHAL,%20Julien&BONIFACE,%20Katia&rft.genre=article


Archivos en el ítem

Thumbnail
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem